Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars
30 avr. 2024 01h00 HE
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Sandoz reaches agreement with Amgen resolving all patent litigation related to its US denosumab biosimilars Agreement...
Sandoz confirms European Commission approval of Pyzchiva® (ustekinumab), further strengthening immunology offering
22 avr. 2024 01h00 HE
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Pyzchiva® approved as one of first ustekinumab biosimilars in EuropeEC approval based on robust development program...
THE BROOKLYN ROASTING COMPANY INTRODUCES TWO SUPER-PREMIUM COFFEE BLENDS TO THE KEURIG® K-CUP® POD SYSTEM
10 avr. 2024 10h00 HE
|
The Brooklyn Roasting Company
Brooklyn, NY, April 10, 2024 (GLOBE NEWSWIRE) -- The Brooklyn Roasting Company, New York's best-loved local roasting company, today announced a new partnership with Keurig Dr Pepper (KDP) with the...
Nerdio Unveils Major Upgrades in Nerdio Manager for Enterprise and Nerdio Manager for MSP, Enhancing Both Platforms
02 avr. 2024 09h00 HE
|
Nerdio
CHICAGO, April 02, 2024 (GLOBE NEWSWIRE) -- Nerdio, a premier solution for organizations of all sizes looking to manage and cost-optimize native Microsoft cloud technologies, today announced...
Sandoz receives FDA approval for first and only denosumab biosimilars
05 mars 2024 13h24 HE
|
Sandoz Group
MEDIA RELEASE Wyost® (denosumab-bddz) and Jubbonti® (denosumab-bddz) interchangeable with and approved by FDA for all indications of reference medicines Xgeva ®* (denosumab) and Prolia®*...
Sandoz acquires CIMERLI® business from Coherus, further building biosimilar and ophthalmology leadership in US market
04 mars 2024 01h00 HE
|
Sandoz Group
MEDIA RELEASE CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®** (ranibizumab injection) for all approved indicationsDedicated retina sales and field reimbursement team...
Sandoz launches first and only biosimilar for multiple sclerosis, Tyruko® (natalizumab), in Germany
31 janv. 2024 01h00 HE
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Tyruko® approved for all indications of reference medicine Tyruko® biosimilar to treat...
Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market
22 janv. 2024 01h00 HE
|
Sandoz Group
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE CIMERLI®*, a ranibizumab biosimilar, is interchangeable with LUCENTIS®**...
Heilind Electronics Features Stewart Connector's IP67 SealJack™ RJ45 Connectors
09 janv. 2024 14h39 HE
|
Heilind Electronics
WILMINGTON, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of interconnect, electromechanical, and sensor products, announces the addition of Stewart...
Weidmüller OMNIMATE® 4.0 Fixed & Pluggable Terminal Blocks Featured at Heilind Electronics
04 janv. 2024 10h30 HE
|
Heilind Electronics
WILMINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Heilind Electronics, a leading global distributor of electronic components and authorized distributor for Weidmüller, is featuring the OMNIMATE®...